Trexquant Investment’s Alpine Immune Sciences Inc ALPN Stock Holding History

Trexquant Investment’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-115,776	Closed	-$4.59M	–	1938
2024 Q1	$4.59M	Buy	115,776 +61,996	+115%	+$1.83M	0.09%	325
2023 Q4	$1.03M	Buy	53,780 +25,202	+88%	+$350K	0.02%	819
2023 Q3	$327K	Sell	28,578 -14,195	-33%	-$175K	0.01%	1194
2023 Q2	$440K	Buy	+42,773	New	+$386K	0.01%	1057
2023 Q1	–	Sell	-16,763	Closed	-$123K	–	1860
2022 Q4	$123K	Buy	16,763 +6,037	+56%	+$38.6K	﹤0.01%	1301
2022 Q3	$77K	Buy	+10,726	New	+$88.4K	﹤0.01%	1295

Trexquant Investment's ALPN Position: Q2 2024 in Review

Trexquant Investment sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 115,776 shares — an estimated $4.59M sold.

Trexquant Investment first reported a position in ALPN in Q3 2022 and held it in 6 quarters. The position peaked at $4.59M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Trexquant Investment reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Trexquant Investment sold 115,776 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.59M.
Trexquant Investment first reported a position in Alpine Immune Sciences Inc in Q3 2022 and held it in 6 quarters.
Trexquant Investment's Alpine Immune Sciences Inc position peaked at $4.59M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.